Increasing the Pentose Phosphate Pathway Flux to Improve Plasmid DNA Production in Engineered E. coli

The demand of plasmid DNA (pDNA) as a key element for gene therapy products, as well as mRNA and DNA vaccines, is increasing together with the need for more efficient production processes. An engineered E. coli strain lacking the phosphotransferase system and the pyruvate kinase A gene has been shown to produce more pDNA than its parental strain. With the aim of improving pDNA production in the engineered strain, several strategies to increase the flux to the pentose phosphate pathway (PPP) were evaluated. The simultaneous consumption of glucose and glycerol was a simple way to increase the growth rate, pDNA production rate, and supercoiled fraction (SCF). The overexpression of key genes from the PPP also improved pDNA production in glucose, but not in mixtures of glucose and glycerol. Particularly, the gene coding for the glucose 6-phosphate dehydrogenase (G6PDH) strongly improved the SCF, growth rate, and pDNA production rate. A linear relationship between the G6PDH activity and pDNA yield was found. A higher flux through the PPP was confirmed by flux balance analysis, which also estimates relevant differences in fluxes of the tricarboxylic acid cycle. These results are useful for developing further cell engineering strategies to increase pDNA production and quality.

[1]  Alvaro R. Lara,et al.  Glucose transport engineering allows mimicking fed-batch performance in batch mode and selection of superior producer strains , 2022, Microbial Cell Factories.

[2]  T. Wysocki,et al.  Queueing theory model of pentose phosphate pathway , 2022, Scientific Reports.

[3]  Alvaro R. Lara,et al.  Vitreoscilla Haemoglobin: A Tool to Reduce Overflow Metabolism , 2021, Microorganisms.

[4]  J. Heinisch,et al.  The Pentose Phosphate Pathway in Yeasts–More Than a Poor Cousin of Glycolysis , 2021, Biomolecules.

[5]  D. Prazeres,et al.  mRNA vaccines manufacturing: Challenges and bottlenecks , 2021, Vaccine.

[6]  J. Ohlson.  Plasmid manufacture is the bottleneck of the genetic medicine revolution , 2020, Drug Discovery Today.

[7]  Alvaro R. Lara,et al.  Plasmid DNA Production in Proteome-Reduced Escherichia coli , 2020, Microorganisms.

[8]  I. Urbatsch,et al.  Bradford Assay for Determining Protein Concentration. , 2020, Cold Spring Harbor protocols.

[9]  T. Hwa,et al.  Regulation underlying hierarchical and simultaneous utilization of carbon substrates by flux sensors in Escherichia coli , 2019, Nature Microbiology.

[10]  Alvaro R. Lara,et al.  Engineering E. coli for improved microaerobic pDNA production , 2019, Bioprocess and Biosystems Engineering.

[11]  Fuzhong Zhang,et al.  Metabolic engineering of the pentose phosphate pathway for enhanced limonene production in the cyanobacterium Synechocystis sp. PCC 6803 , 2017, Scientific Reports.

[12]  D. Klostermeier,et al.  Binding and Hydrolysis of a Single ATP Is Sufficient for N-Gate Closure and DNA Supercoiling by Gyrase. , 2017, Journal of molecular biology.

[13]  K. Shimizu,et al.  Elucidation of the co-metabolism of glycerol and glucose in Escherichia coli by genetic engineering, transcription profiling, and 13C metabolic flux analysis , 2016, Biotechnology for Biofuels.

[14]  S. Kowalczykowski,et al.  RecA: Regulation and Mechanism of a Molecular Search Engine. , 2016, Trends in biochemical sciences.

[15]  J. Queiroz,et al.  Enhanced biosynthesis of plasmid DNA from Escherichia coli VH33 using Box–Behnken design associated to aromatic amino acids pathway , 2015 .

[16]  M. Domach,et al.  Effect of plasmid replication deregulation via inc mutations on E. coli proteome & simple flux model analysis , 2015, Microbial Cell Factories.

[17]  Estelle Crozat,et al.  Resolution of Multimeric Forms of Circular Plasmids and Chromosomes , 2014, Microbiology spectrum.

[18]  Alvaro R. Lara,et al.  Effect of growth rate on plasmid DNA production and metabolic performance of engineered Escherichia coli strains. , 2014, Journal of bioscience and bioengineering.

[19]  Alvaro R. Lara,et al.  Engineering Escherichia coli to increase plasmid DNA production in high cell-density cultivations in batch mode , 2012, Microbial Cell Factories.

[20]  Christoph Wittmann,et al.  Consequences of phosphoenolpyruvate:sugar phosphotranferase system and pyruvate kinase isozymes inactivation in central carbon metabolism flux distribution in Escherichia coli , 2012, Microbial Cell Factories.

[21]  G. Monteiro,et al.  De novo creation of MG1655-derived E. coli strains specifically designed for plasmid DNA production , 2012, Applied Microbiology and Biotechnology.

[22]  K. Prather,et al.  De novo creation of MG1655-derived E. coli strains specifically designed for plasmid DNA production , 2012, Applied Microbiology and Biotechnology.

[23]  Filomena Silva,et al.  Evaluating metabolic stress and plasmid stability in plasmid DNA production by Escherichia coli. , 2012, Biotechnology advances.

[24]  Alvaro R. Lara,et al.  High cell-density cultivation in batch mode for plasmid DNA production by a metabolically engineered E. coli strain with minimized overflow metabolism , 2011 .

[25]  Adam M. Feist,et al.  A comprehensive genome-scale reconstruction of Escherichia coli metabolism—2011 , 2011, Molecular systems biology.

[26]  G. Monteiro,et al.  Rational engineering of Escherichia coli strains for plasmid biopharmaceutical manufacturing , 2011, Biotechnology journal.

[27]  Amin Espah Borujeni,et al.  Genome‐derived minimal metabolic models for Escherichia coli MG1655 with estimated in vivo respiratory ATP stoichiometry , 2010, Biotechnology and bioengineering.

[28]  G. Sahni,et al.  Enhanced production of recombinant streptokinase in Escherichia coli using fed-batch culture. , 2009, Bioresource technology.

[29]  James A. Williams,et al.  Generic plasmid DNA production platform incorporating low metabolic burden seed‐stock and fed‐batch fermentation processes , 2009, Biotechnology and bioengineering.

[30]  M. Domach,et al.  Factors affecting plasmid production in Escherichia coli from a resource allocation standpoint , 2009, Microbial cell factories.

[31]  R. Gonzalez,et al.  A new model for the anaerobic fermentation of glycerol in enteric bacteria: trunk and auxiliary pathways in Escherichia coli. , 2008, Metabolic engineering.

[32]  M. L. Narasu,et al.  Impact of dissolved oxygen concentration on some key parameters and production of rhG-CSF in batch fermentation , 2008, Journal of Industrial Microbiology & Biotechnology.

[33]  K. Friehs,et al.  Structures of Plasmid DNA , 2007 .

[34]  Ronan M. T. Fleming,et al.  Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0 , 2007, Nature Protocols.

[35]  A. Khodursky,et al.  RecA can stimulate the relaxation activity of topoisomerase I: Molecular basis of topoisomerase-mediated genome-wide transcriptional responses in Escherichia coli , 2006, Nucleic acids research.

[36]  G. Węgrzyn,et al.  Effects of the presence of ColE1 plasmid DNA in Escherichia coli on the host cell metabolism , 2006, Microbial Cell Factories.

[37]  M. Eiteman,et al.  Overcoming acetate in Escherichia coli recombinant protein fermentations. , 2006, Trends in Biotechnology.

[38]  Steve Oh,et al.  Global transcriptional analysis of metabolic burden due to plasmid maintenance in Escherichia coli DH5α during batch fermentation , 2006 .

[39]  Guillermo Gosset,et al.  Growth‐rate recovery of Escherichia coli cultures carrying a multicopy plasmid, by engineering of the pentose‐phosphate pathway , 2004, Biotechnology and bioengineering.

[40]  J. Büchs,et al.  Online respiration activity measurement (OTR, CTR, RQ) in shake flasks , 2004 .

[41]  J. Courcelle,et al.  DNA Damage-Induced Replication Fork Regression and Processing in Escherichia coli , 2003, Science.

[42]  V. Saraswat,et al.  Effect of specific production rate of recombinant protein on multimerization of plasmid vector and gene expression level. , 1999, FEMS microbiology letters.

[43]  D. Summers,et al.  Multicopy plasmid instability: the dimer catastrophe hypothesis , 1993, Molecular microbiology.

[44]  A. James,et al.  recA-independent general genetic recombination of plasmids , 1981, Nature.

[45]  Alvaro R. Lara,et al.  Advances in host and vector development for the production of plasmid DNA vaccines. , 2014, Methods in molecular biology.

[46]  Guidance for Industry Considerations for Plasmid DNA Vaccines for Infectious Disease Indications Contains Nonbinding Recommendations Draft-Not for Implementation , 2005 .

[47]  R. J. Reece,et al.  DNA gyrase: structure and function. , 1991, Critical reviews in biochemistry and molecular biology.